TechSlashdot1h ago
Moderna-Merck Vaccine Cuts Recurrence And Spread of Melanoma, Raises
Moderna-Merck Vaccine Cuts Recurrence And Spread of Melanoma, Raises New Treatment Hope
TL;DRModerna and Merck's personalized mRNA vaccine reduced melanoma recurrence in late-stage trials.
Why it matters: mRNA technology expands beyond COVID into cancer treatment, potentially transforming oncology with personalized therapies.
Reuters reports "a major success in a new field of cancer treatment this week, as Moderna and Merck announced a personalized mRNA cancer vaccine "reduced the risk of recurrence and spread of melanoma in a late-stage trial". The vaccine was tested with Merck's widely used…
Read full articleSource: Slashdot · Opens in new tab